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Screening for infectious diseases of asylum
seekers upon arrival: the necessity of the
moral principle of reciprocity
Dorien T. Beeres1* , Darren Cornish2, Machiel Vonk3, Sofanne J. Ravensbergen1, Els L. M. Maeckelberghe4,
Pieter Boele Van Hensbroek5 and Ymkje Stienstra1
Abstract
Background: With a large number of forcibly displaced people seeking safety, the EU is facing a challenge in
maintaining solidarity. Europe has seen millions of asylum seekers crossing European borders, the largest number of
asylum seekers since the second world war. Endemic diseases and often failing health systems in their countries of
origin, and arduous conditions during transit, raise questions around how to meet the health needs of this
vulnerable population on arrival in terms of screening, vaccination, and access to timely and appropriate statutory
health services. This paper explores the potential role of the principle of reciprocity, defined as the disposition ‘to
return good in proportion to the good we receive, and to make reparations for the harm we have done’, as a mid-level
principle in infectious disease screening policies.
Main text: More than half of the European countries implemented screening programmes for newly arrived asylum
seekers. Screening may serve to avoid potential infectious disease risks in the receiving countries as well as help
identify health needs of asylum seekers. But screening may infringe upon basic rights of those screened, thus
creating an ethical dilemma.
The use of the principle of reciprocity can contribute to the identification of potential improvements for current
screening programmes and emphasizes the importance of certain rights into guidelines for screening. It may create
a two way moral obligation, upon asylum seekers to actively participate in the programme, and upon authorities to
reciprocate the asylum seekers’ participation and the benefits for the control of public health.
Conclusion: The authors argue that the reciprocity principle leads to a stronger ethical justification of screening
programmes and help achieve a balance between justifiable rights claims of the host population and the asylum
seekers. The principle deserves a further and more thorough exploration of its potential use in the field of
screening, migration and infectious diseases.
Keywords: Reciprocity, Screening, Migration, Infectious diseases, Asylum seeker
Background
In 2016, the number of forcibly displaced people rose
worldwide to 60 million [1]. More than 1.2 million
people have crossed the Mediterranean Sea to Europe
between January 2015 and May 2016 [2]. Arduous con-
ditions during flight routes and endemic diseases in their
countries of origin lead to questions on how to identify
and meet the health needs of this vulnerable population.
More than half of the European countries reported to
have implemented screening programmes that target
newly arrived asylum seekers in 2014 [3]. Screening1 for
infectious diseases aims to serve two different goals,
namely to protect public health by identifying those
considered to be a potential source of spreading an
infectious disease, and to identify individuals who may
benefit from health care so that they can be offered such
care [4]. In 2014, a questionnaire-based study described
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current screening activities for infectious diseases among
newly arrived migrants in EU/EEA countries [3]. Of the
27 EEA/EU countries, 15 implemented screenings
among newly arrived asylum seekers. Most common
screening programmes are for tuberculosis (15/15),
Hepatitis B (5/15), HIV (4/15), and Hepatitis C (4/15)
[3]. The World Health Organization (WHO) does not
recommend compulsory mass screening of the asylum
seeker population for infectious diseases because there is
no clear evidence proving the effectiveness of screening.
Furthermore, screening may create anxiety and reluc-
tance to seek care because asylum seekers may fear that
positive test results influence their application procedure
[5, 6]. Instead, the WHO and the European Centre for
Disease Prevention and Control (ECDC) advise Euro-
pean countries to provide general health checks and im-
prove sanitation and vaccination programmes to prevent
outbreaks of infections like measles and influenza [7].
The implementation of various screening programmes
and the variation in national guidelines on screening
evoke questions about normative justification of such
programmes. Policies on screening are not exclusively
dependent on the relative risk of infection, but also on
non-medical grounds, such as economic, political and
emotional ones [2, 4]. Incidences of infectious diseases
are often misinterpreted by politicians and the press as a
threat. However, epidemiological studies show that this
risk is substantially lower than often perceived [2, 5].
While comprehensive data on infectious disease risks
are not yet available, it has been shown that some sub-
groups of asylum seekers are more affected by several in-
fectious diseases (HIV, tuberculosis and Chagas disease) as
compared to the host population [8]. However, there is
only a limited risk of disease transmission to the host-
population [8]. It is of normative relevance to discuss the
proper balance between the state’s obligations to secure
public health for all and at the same time to protect the
individual rights and needs of asylum seekers.
For assessing these tensions, thoughtful evaluation of
moral dilemmas and the values involved is essential. Up
to now, the ‘harm principle’ is often mentioned as mid-
level normative principle2 for addressing the described di-
lemma in public health. In modern states, even in liberal
ones, the obligation to protect the public from serious
harm is a foundational principle of public health ethics,
and often considered the most compelling justification for
public health policies that interfere with individual liberty
[10–12]. However, the principle of reciprocity has gained
increased attention during the past years. Reciprocity is
generally formulated as the disposition “to return good in
proportion to the good we receive, and to make reparations
for the harm we have done” (Becker 1986 p.3) and is con-
sidered an important requirement for ethically acceptable
public health interventions and screening in a liberal
society [13–15]. This principle can be used as a guiding
principle in public health issues that are challenged to
both fulfil public health duties and at the same time serve
individual interests [15, 16].
The aim of this paper is to critically assess the poten-
tial role of reciprocity as normative decision and justifi-
cation principle for screening programmes for asylum
seekers. Normative decisions are decisions based on
philosophical moral theories on what is valuable (i.e,
“what we ought to do”), and moral justification is based
on the values set by the related normative principle. The
first part of this paper discusses the principle of reci-
procity and the way it can be used. The second part
evaluates the current practice of screening programmes
at reception centres in Europe in the light of reciprocity,
thereby assessing the potential of the principle of reci-
procity for evaluating the ethical dimension of such
screening programmes.
The principle of reciprocity as a mid-level principle for
infectious disease control
The implementation of screening often results in con-
flicting interests and creates a tension between the obli-
gation of the state to protect the health of the public on
one hand, and respecting the autonomy, health interests,
and liberty of the screened individuals on the other [16].
The concept of reciprocity may be a helpful notion in
analysing such tensions. Literature in the social sciences
shows that reciprocity increases the willingness for social
cooperation [17]. In public health ethics there is an in-
creasing interest in using reciprocity as a mid-level,
action-guiding principle [15]. For instance, the principle
is used as instrument to legitimize and justify limitations
on human rights in public health emergencies that re-
quire restrictive measurements [18]. The SARS outbreak
in 2004, the recent Ebola outbreak in 2014, and the con-
tinuing discussions around tuberculosis treatment and
control have led to some clear formulations of reci-
procity in public health ethics [16, 19–21].
While the principle of reciprocity has been formulated
in different contexts, virtue theorist Lawrence Becker ar-
ticulated the most well-known classical formulation of
reciprocity as the disposition “to return good in propor-
tion to the good we receive, and to make reparations for
the harm we have done” (Becker 1986, 3). Viens and col-
leagues formulated this conception of reciprocity for
public health ethics:
“Reciprocity demands an appropriate balancing of the
benefits and burdens of social cooperation necessary
to obtain the good of public health. (…) Reciprocity
requires that we compensate those disproportionately
burdened by complying with restrictive measures and
make restitution to those individuals wronged by
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being subjected to unfair or intolerable treatment.
Reciprocity not only requires that individuals should
not be overly burdened by measures to protect public
health, but also that individuals are supported in a
way that allows them to fulfil their obligations”
(Viens, Bensimon, and Upshur 2009, ref [21], page
211−212).
Seven years later, Silva, Dawson, and Upshur build on
this formulation towards a more general definition as:
“Reciprocity is a moral obligation involving an
appropriate response by B commensurate with an
action by A, where A’s action aims to contribute to, or
bring about, public good, and where the action
involves burdens, costs, or risks of harm to A” (Silva,
Dawson, and Upshur 2016, ref [15], page 84).
This definition includes several key features that can be
formulated in the context of infectious disease screening
as: First, that the asylum seeker (A) complies to active par-
ticipation in the programme with the aim to identify pres-
ence or absence of disease (i.e., contribution to public
good). Second, the authorities organizing the screening
(B) have an obligation to respond well to the asylum
seekers participation in the screening and consequently
the test results of the person being screened. This may in-
clude, among other things, explanation of the procedure,
explanation of consequences of positive and negative test
results, and providing accessible treatment.
In addition to its direct goods and harms to the in-
volved parties, the reciprocity principle has also indirect
beneficial influences [15]. Indirect moral power can be
defined as a person or institution contributing to a sys-
tem, e.g. the screening programme, without necessarily
receiving direct individual benefit or observing others re-
ceiving benefit. Acting upon this principle is based on a
more general normative value of social cooperation for
the public good. Reciprocity generates strong bonds of
solidarity among groups, and has proven to be more ef-
fective than placing the burdens and benefits upon a
small group of individuals [18, 22, 23]. Moreover, reci-
procity as an indirect moral power can be considered a
form of (social) justice, where inequalities among asylum
seekers and host populations in general create duties to-
wards each other [15].
General criteria for screening programmes
While clear international guidelines for screening pro-
grammes for infectious diseases at reception centres are
lacking, general guidelines for screening are available. In
contrast to other national screening programmes that tar-
get specific groups (e.g. cervical and breast cancer screen-
ing programmes), the case of asylum seeker screening is
more complex. The timing of these screening programmes
as part of the asylum procedure may lead to ideas that the
outcomes may influence their asylum procedure. The fre-
quently limited access to health care makes it challenging
for health care providers to meet refugees’ health needs.
In addition, a wide cultural variation within asylum seeker
populations requires a screening programme with extra
attention for cultural sensitive care [24]. Internationally,
screening programmes must be in accordance with a
regulative framework provided by the WHO. These clas-
sical screening criteria were established by Wilson and
Jungner in 1968 (Table 1). In 2008, the WHO added add-
itional requirements (Table 2) in response to technical
and medical advancements [25].
These criteria require a programme to focus on im-
portant health issues, produce benefits to the public
while minimizing harm to the individual, fairly distribut-
ing benefits and burdens, and the intervention in the
programme must be proportional [25]. Moreover, the re-
quirement to enforce participation in the screening must
be proportionate in view of the public health emergency.
Although the WHO guidelines effectively set a high
standard for screening, the principle of reciprocity priori-
tizes several aspects that are not explicitly addressed in
the WHO criteria. The principle goes beyond require-
ments on the quality and appropriateness of the screening.
Authorities will be urged to reciprocate participation in
screening with assisting the individual (or the community)
in the fulfilment of their health care needs, including iden-
tification of personal health needs and providing access-
ible treatment when needed [26].
Role of reciprocity in screening programmes for
infectious diseases that target asylum seekers
The final section of this paper assesses the possible role
of reciprocity in the existing screening programmes.
Table 1 Wilson and Jungner screening criteria [40]
1. The condition sought should be an important health problem.
2. There should be an accepted treatment for patients with
recognized disease.
3. Facilities for diagnosis and treatment should be available.
4. There should be a recognizable latent or early symptomatic stage.
5. There should be a suitable test or examination.
6. The test should be acceptable to the population.
7. The natural history of the condition, including development from
latent to declared disease, should be adequately understood.
8. There should be an agreed policy on whom to treat as patients.
9. The cost of case-finding (including diagnosis and treatment of
patients diagnosed) should be economically balanced in relation
to possible expenditure on medical care as a whole.
10. Case-finding should be a continuing process and not a “once and
for all” project
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Currently, a few studies are available which describe
practical experiences with infectious disease screening of
asylum seekers [6, 27–29]. While there is an increasing
interest in studies describing asylum seekers’ experi-
ences, none of them have extensively addressed the role
of normative principles in decision-making, justifica-
tion, or evaluation of these specific screening pro-
grammes. The complex character of asylum seeker
screening that is mentioned in the previous para-
graph, such as their refugee status and cultural differ-
ences, shows the necessity to examine the moral
underpinnings of these programmes.
The literature on current screening programmes in
Europe shows two ‘levels’ of shortcomings; On policy
level regarding the limited scope of the current screen-
ing programmes and shortcomings that concern prac-
tical issues related to the implementation of such
programmes. The most extensive studies concern tuber-
culosis screening in the UK and the overall health as-
sessments in Sweden. These British and Swedish
programmes can help to reflect on other programmes in
Europe, and comparing these two distinctive pro-
grammes reveals common as well as programme specific
challenges. The mandatory tuberculosis screening as in
the UK is implemented in several European countries
such as in Belgium, Germany, the Netherlands, and
Switzerland [30].
The examples of the UK and Sweden
In the UK, medical examination may be required for any
person who is neither a national of the European Eco-
nomic Area (EEA) or a UK citizen. Medical examination
can take place abroad (as part of visa application), upon
arrival at a port of entry, or after entry. All persons arriv-
ing from countries with a high incidence of tuberculosis
are required to undergo medical screening for the active
form of tuberculosis. However, usually screening is only
performed among persons who seek to remain in the
UK for more than six months [31, 32]. For persons who
are clearly unwell, a medical examination can be re-
quired. If there is a medical condition that has impact
upon applicants’ ability to maintain themselves, or if an
applicant represents a risk to the national public health,
entry to the UK can be refused [31, 32].
Studies addressing experiences with entry screening for
tuberculosis frequently report language barriers, cultural
differences, fear for discrimination, and stigmatization. In
addition, there is a lack of evidence for the effectiveness
and efficiency of the screening [2, 6, 27, 28, 33–35]. A
study by Seedat et al. (2014) interviewed UK immigrant
community health-care leads representing new migrant
groups (refugees, asylum seekers and foreign-born individ-
uals that recently arrived in the UK and came from high
prevalence disease countries) in London about their views
on screening of migrants. This study observed that the
current tuberculosis screening in the UK is often per-
ceived to be migrant unfriendly. The study describes con-
cerns among migrants about cultural insensitivity within
the services, inhospitable and unfriendly experiences when
accessing the services, and discrimination by health-care
professionals [6]. Migrants prefer a general health check-
up instead of limited tuberculosis screening. They believe
that this will better meet their health needs and reduce
stigma [6].
How can the principle of reciprocity guide the British
programme? The principle suggests that the benefit of
identification of infected individuals to prevent out-
breaks creates the reciprocal moral obligation of the au-
thorities to identify other health needs of the asylum
seeker apart from tuberculosis and guide them to proper
treatment opportunities. Reports of the WHO observe
that asylum seekers in general have health problems
similar to the host population of receiving countries [5].
To illustrate, the tuberculosis prevalence in Syria is sub-
stantially lower than the tuberculosis prevalence in
European countries like Bulgaria, Portugal, Poland, and
Romania [5, 36]. However, the epidemiological back-
ground and the arduous journey many asylum seekers
have endured, might increase the risk for mental health
problems and the vulnerability to non-communicable
(e.g. travel injuries, hypertension) as well as communic-
able diseases [2, 5]. Asylum seekers are likely to benefit
from early diagnosis and treatment, which suggests
screening and treatment within the first six months after
arrival [36]. Further studies are needed to investigate the
best timing of screening. Finally, adequate assessment of
immunisation status is important among asylum seeker
populations originating from countries with interrupted
vaccination programmes.
Table 2 Synthesis of emerging screening criteria proposed over
the past 40 years [25]
1. The screening programme should respond to a recognized need.
2. The objectives of screening should be defined at the outset.
3. There should be a defined target population.
4. There should be scientific evidence of screening programme
effectiveness.
5. The programme should integrate education, testing, clinical
services and programme management.
6. There should be quality assurance, with mechanisms to minimize
potential risks of screening.
7. The programme should ensure informed choice, confidentiality
and respect for autonomy.
8. The programme should promote equity and access to screening
for the entire target population.
9. Programme evaluation should be planned from the outset.
10. The overall benefits of screening should outweigh the harm.
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Summarizing, the present tuberculosis screening
programme can be used as a starting point for further
mental and physical examination which gives the op-
portunity for health care interventions for asylum
seekers at an early stage. Such an approach, following
Molms’ theory on the power of reciprocity in social
cooperation, will stimulate asylum seekers to actively
participate in these programmes [17].
Health assessments in Sweden
While in most European countries disease screening is
limited to tuberculosis screening, in Sweden, the Na-
tional Board of Health and Welfare (NHWB) offer adult
and child migrants health screening soon after arrival in
accordance with the Act (2008:344) on Health Care for
Asylum Seekers and ‘Others’, and the Communicable
Disease Act (2004:168) [27]. The health screening is per-
formed soon after arrival, by local health services and is
free of charge. The screening includes: an interview
about the newcomer’s past and current physical and
mental health, vaccination status, and information that
may be needed from infection control standpoint. A
physical examination and blood test may be performed
if necessary [27]. While the health screening in Sweden
is voluntary, it can be compulsory under the Communic-
able Disease Act [37].
The study by Nkulu Kalengayi et al. (2016) describes
asylum seekers’ experiences with the health screening in
Sweden and shows that the asylum seekers acknowledge
that the screening is both beneficial for the host society
and for themselves - being grateful to be given the op-
portunity to have their health status checked. However,
they stated that the screening did not meet their expec-
tations. They experienced the screening to be mainly fo-
cused on the identification of infectious diseases instead
of identification of their health needs [27]. Additionally,
the study describes a major concern among asylum
seekers that screening outcomes negatively influence
their residency. This concern about residency is de-
scribed to be more important to them than identification
of their health needs [27]. It is important to take this
finding into account in future strategies given the fact
that the timing of screening could have large impact on
the uptake of these programmes.
Limitations on the principle
While this paper advocates for a directive role of the
principle of reciprocity in health policies, there are chal-
lenges. A possible objection against the use of reci-
procity as a guiding principle in the context of infectious
disease screening of asylum seekers could be to argue
that the primary goal of active participation of the asy-
lum seeker is not serving public good, but to serve indi-
vidual benefit (identification of the most important
heath needs of the asylum seeker). This assumption may
exempt authorities from a moral obligation to compen-
sate for the public health benefits received since the ben-
efits of screening initially serve the individual. However,
this objection may be countered by stating that screen-
ing solely focused on infectious diseases ignores non-
communicable diseases such as mental health problems
that pose a bigger threat than communicable diseases on
asylum seekers [5, 37].
Second, the obligations and responsibilities that are
discussed in the article come from an ethical back-
ground, describing actions as they ‘ought to be’. Practical
experiences with screening, such as arguments on cost-
effectiveness of screening programmes, could create a ten-
sion with the arguments derived from the reciprocity
principle. While hepatitis screening could be cost-effective
on the long-term [38], implementation of screening pro-
grammes may result in financial problems on short-term
[39]. Increased case identification as a result of the
programme could possibly lead to an enormous rise in
treatment costs, where the burden on the national health
care coverage leads to more harm than the benefits re-
ceived for the individuals being screened. In these circum-
stances, moral obligations may describe needs or require
resources that could not be met. Re-evaluation of moral re-
sponsibilities by balancing benefits and costs is important.
Finally, it is a challenge to identify the best practice
that is needed to create an environment that invites both
parties to reciprocate to the greatest degree and fulfil
their moral obligations. As described in the Swedish
study, concerns about residency among asylum seekers
and fear for authorities negatively influences active par-
ticipation among asylum seekers in screening pro-
grammes. Given that this could have a large impact on
the uptake and efficacy of screening, it is important to
further investigate best practice. Similarly, European
countries face responsibilities towards each other to co-
operate on screening programmes and health policies in
the light of reciprocity. Cooperation is important to
avoid unnecessary replication of diagnostics and treat-
ment and to avoid country specific preferences among
asylum seekers based on differences in screening and
health services on arrival, which may result in an unbal-
anced burden on several countries. Both timing and
international agreements are needed to effectively bal-
ance moral obligations of both parties and invite host
countries to provide best services.
Conclusions
Reciprocity goes beyond prevention of harm. The current
WHO screening guidelines create obligations for author-
ities to guarantee the quality of screening programmes,
but the inclusion of moral obligations is limited. The use
of the reciprocity principle could effectively mend this
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limitation, and deserves a further and more thorough ex-
ploration of its potential use in the field of screening, mi-
gration and infectious diseases.
The principle identifies limitations in current screen-
ing programmes and emphasizes the importance of cer-
tain rights (e.g. autonomy, right to health) into
guidelines for screening. It creates a moral obligation
upon authorities to reciprocate the asylum seekers’
forced participation and the benefits for the control of
public health. The attention to the reciprocity norm sug-
gests two ‘levels’ at which current screening programmes
can be improved.
Screening is made beneficial for the asylum seekers if
it is not limited to only infectious diseases identification,
but takes a more holistic approach by focussing on men-
tal and physical health problems, including vaccination
and prevention programmes and accessible information
about the national healthcare system [27, 35]. Second,
the screening process requires that the benefits for the
receiving society and the obligation for the asylum
seekers to respond and actively participate in the
programme are balanced with health benefits of those
screened, who see the screening followed-up by ad-
equate general health care.
Endnotes
1In the context of this article screening means the sys-
tematic application of a medical test to a defined popula-
tion (e.g. asylum seekers) with the purpose to identify
those with undetected disease.
2Moral mid-level principles are moral principles in
which their application is specialized within a specific
field. They stand in between unconditional principles
(e.g. impartiality) and context-specific obligations [9].
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